Bivictrix Therapeutics

RNS Announcement

RNS Number : 9398C

FTSE Russell

04 September 2024

Bivictrix Therapeutics (UK): Constituent Deletion
Changes in FTSE UK Index Series

04 September 2024

Subject to the expected cancellation of trading on AIM for Bivictrix Therapeutics (UK, constituent), please see details of affected indexes and effective dates below:

Index	Effective From Start of Trading
FTSE AIM All-Share Index	11 September 2024

For further information please contact FTSE Russell Client Services at [email protected] or call:

Australia	+61 (0) 2 7228 5659
Hong Kong	+852 2164 3333
Japan	+81 3 6441 1430
London	+44 (0) 20 7866 1810
New York	+1877 503 6437

Alternatively please visit our website at lseg.com/ftse-russell

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

FTSFLFLEAFISIIS

RNS metadata

Title: Bivictrix Therapeutics
Time: 17:30:00
Date: 4 Sept 2024
Category: Miscellaneous
ID: 9398C